The present study aimed to investigate the effects of metformin on BS control, CRP levels (as an inflammatory marker), ACT score, PFT including FEV1, FVC, and FEV1 to FVC ratio, and clinical outcomes in patients with concurrent asthma and MetS. The gene discussed is CRP; the disease is asthma.